Literature DB >> 11911591

Equine herpesvirus type 1 (EHV-1) myeloencephalopathy: a case report.

B Stierstorfer1, W Eichhorn, W Schmahl, C Brandmüller, O R Kaaden, A Neubauer.   

Abstract

An outbreak of neurological disease occurred in a well-managed riding school. Ataxia and paresis were observed in several horses, five of which became recumbent and were euthanized. Post-mortem analysis revealed scattered haemorrhages along the spinal cord, that were reflected by multiple haemorrhagic foci on formalin-fixed sections, with the thoracic and lumbar segments being the most affected. Pathohistologically, perivascular mononuclear cuffing and axonal swelling, especially in the white matter, were evident. Parallel to the course of disease, alterations in myelin sheets and activation of astrocytes and microglial cells were also observed. Virological findings confirmed an acute equine herpesvirus type 1 infection and virus was isolated from the spinal cord of a 26-year-old mare.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11911591     DOI: 10.1046/j.1439-0450.2002.00537.x

Source DB:  PubMed          Journal:  J Vet Med B Infect Dis Vet Public Health        ISSN: 0931-1793


  7 in total

1.  Single amino acid residue in the A2 domain of major histocompatibility complex class I is involved in the efficiency of equine herpesvirus-1 entry.

Authors:  Michihito Sasaki; Eunmi Kim; Manabu Igarashi; Kimihito Ito; Rie Hasebe; Hideto Fukushi; Hirofumi Sawa; Takashi Kimura
Journal:  J Biol Chem       Date:  2011-09-26       Impact factor: 5.157

2.  Equine Herpesvirus Type 1 Enhances Viral Replication in CD172a+ Monocytic Cells upon Adhesion to Endothelial Cells.

Authors:  Kathlyn Laval; Herman W Favoreel; Katrien C K Poelaert; Jolien Van Cleemput; Hans J Nauwynck
Journal:  J Virol       Date:  2015-08-19       Impact factor: 5.103

3.  Equine herpesvirus-1, non-neurogenic pathotype, in a 9-year-old American Saddlebred with neurological signs.

Authors:  Tammy M-J Heerkens
Journal:  Can Vet J       Date:  2009-03       Impact factor: 1.008

4.  Pharmacokinetics of acyclovir after intravenous infusion of acyclovir and after oral administration of acyclovir and its prodrug valacyclovir in healthy adult horses.

Authors:  B Garré; K Shebany; A Gryspeerdt; K Baert; K van der Meulen; H Nauwynck; P Deprez; P De Backer; S Croubels
Journal:  Antimicrob Agents Chemother       Date:  2007-09-10       Impact factor: 5.191

5.  Equine major histocompatibility complex class I molecules act as entry receptors that bind to equine herpesvirus-1 glycoprotein D.

Authors:  Michihito Sasaki; Rie Hasebe; Yoshinori Makino; Tadaki Suzuki; Hideto Fukushi; Minoru Okamoto; Kazuya Matsuda; Hiroyuki Taniyama; Hirofumi Sawa; Takashi Kimura
Journal:  Genes Cells       Date:  2011-02-10       Impact factor: 1.891

6.  Equid herpesvirus-1 Distribution in Equine Lymphoid and Neural Tissues 70 Days Post Infection.

Authors:  Susanna Samoilowa; Kim S Giessler; Carlos E Medina Torres; Gisela Soboll Hussey; Allison Allum; Robert Fux; Christin Jerke; Matti Kiupel; Kaspar Matiasek; Dodd G Sledge; Lutz S Goehring
Journal:  Pathogens       Date:  2021-06-05

7.  A point mutation in a herpesvirus polymerase determines neuropathogenicity.

Authors:  Laura B Goodman; Arianna Loregian; Gillian A Perkins; Josie Nugent; Elizabeth L Buckles; Beatrice Mercorelli; Julia H Kydd; Giorgio Palù; Ken C Smith; Nikolaus Osterrieder; Nicholas Davis-Poynter
Journal:  PLoS Pathog       Date:  2007-11       Impact factor: 6.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.